Candid Health Wraps $120M Series D Funding Round
Autonomous revenue cycle management platform Candid Health, advised by Lowenstein Sandler LLP, on Wednesday revealed that it raised $120 million in its latest funding round, marking a three-times increase in valuation...To view the full article, register now.
Already a subscriber? Click here to view full article